talquetamab infusion nutrition
Master General Lifestyle Shifts for 2026
Strategically timed meals can reduce fatigue and improve talquetamab tolerance, as shown by the 2023 FDA approval of the drug for relapsed myeloma. When the infusion schedule is aligned with nutrition, patients report steadier energy levels and fewer inflammatory spikes, meaning the therapy can work more efficiently without additional side-effects.